findmyKOL

Amrita Krishnan, MD

Enriched profile

Nason-Hollingsworth Endowed Chair for Multiple Myeloma; Executive Medical Director of Hematology, City of Hope Orange County; Chair, SWOG Barlogie-Salmon Myeloma Committee (as of Nov 1, 2025) · City of Hope

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Duarte, CA · West · United StatesSpecialtyHematologyFocusHematology
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding1999–2009Why? →

Amrita Krishnan is Nason-Hollingsworth Endowed Chair for Multiple Myeloma; Executive Medical Director of Hematology, City of Hope Orange County; Chair, SWOG Barlogie-Salmon Myeloma Committee (as of Nov 1, 2025) at City of Hope. ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Amrita Krishnan, MD, is Nason-Hollingsworth Endowed Chair for Multiple Myeloma at City of Hope (Orange County Lennar Foundation Cancer Center / Briskin Center for Multiple Myeloma Research, Duarte). It also documents an investigator role on 14 registered clinical trials, industry payments reported by 22 companies, 1 NIH-funded awards (1999–2009).

  • Top research focus: Hematology
  • 14 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 22 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lymphoma7 trialsMultiple Myeloma6 trialsHIV3 trialsHodgkin Disease3 trialsAcquired Immunodeficiency Syndrome2 trialsLymphoma, Non-Hodgkin2 trialsLymphoma, Primary Effusion2 trialsPlasmablastic Lymphoma2 trialsLymphoma, Large B-Cell, Diffuse2 trialsLymphoma, B-Cell2 trialsAmyloidosis2 trialsBurkitt Lymphoma1 trialLeukemia (AML/ALL/CML/CLL)1 trialLeukemia, Plasma Cell1 trial

Research focus

OpenAlex concept fingerprint
Hematology

Drugs & molecules

across trials, industry payments and publications
Blenrepgeneric · Belantamab mafodotinClinical trials—Industry payments41Publications—Darzalexgeneric · DaratumumabClinical trials—Industry payments19Publications—Pomalystgeneric · PomalidomideClinical trials—Industry payments16Publications—Sarclisageneric · IsatuximabClinical trials—Industry payments16Publications—Carvyktigeneric · Ciltacabtagene autoleucelClinical trials—Industry payments13Publications—Ninlarogeneric · IxazomibClinical trials—Industry payments12Publications—Talveygeneric · TalquetamabClinical trials—Industry payments10Publications—Tecvayligeneric · TeclistamabClinical trials—Industry payments7Publications—Kyprolisgeneric · CarfilzomibClinical trials—Industry payments4Publications—Elrexfiogeneric · ElranatamabClinical trials—Industry payments3Publications—Venclextageneric · VenetoclaxClinical trials—Industry payments3Publications—Abecmageneric · Idecabtagene vicleucelClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
GlaxoSmithKline, LLC.Clinical trials—Industry payments58E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments34Genzyme CorporationClinical trials—Industry payments20Janssen Biotech, Inc.Clinical trials—Industry payments18Abbvie Inc.Clinical trials—Industry payments15City of Hope Medical CenterClinical trials12Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments12Celgene CorporationClinical trials—Industry payments9Pfizer Inc.Clinical trials—Industry payments9AstraZeneca Pharmaceuticals LPClinical trials—Industry payments8F. Hoffmann-La Roche AGClinical trials—Industry payments6Adaptive Biotechnologies CorporationClinical trials—Industry payments5Legend Biotech USA Inc.Clinical trials—Industry payments5Amgen Inc.Clinical trials—Industry payments4Janssen Global Services, LLCClinical trials—Industry payments4Janssen Research & Development, LLCClinical trials—Industry payments3Genentech USA, Inc.Clinical trials—Industry payments2Genentech, Inc.Clinical trials—Industry payments2AstraZeneca UK LimitedClinical trials—Industry payments1Coherus Biosciences Inc.Clinical trials—Industry payments1Epizyme, Inc.,Clinical trials—Industry payments1Janssen Scientific Affairs, LLCClinical trials—Industry payments1Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments1Sheba Medical CenterClinical trials1Industry payments—SWOG Cancer Research NetworkClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
59h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials ↓
22companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 1999–2009

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

All 14 trial records: search, sort and filter.Explore →

Industry payments

Updated 16 Oct 2026

22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 49 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    99.6%
    CD38-directed Cytolytic Antibody99.6%
    Daratumumab100%
    Part B, office-administered≥16 patients

  • Dermatology

    0.3%
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.3%
    Acyclovir100%
    Part D<11 patients

  • Metabolism & gastrointestinal

    0.1%
    Serotonin-3 Receptor Antagonist0.1%
    Ondansetron Hcl100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 16 Oct 2026

1 NIH research award on record, funded 1999–2009 per NIH RePORTER. The latest:

All 19 award records: search, sort and filter.Explore →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/amrita-krishnan-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Doximity

    doximity.com/pub/amrita-krishnan-md-cf4a7f71

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/DoctorAKrishnan

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Spotify

    creators.spotify.com/pod/profile/astct/episodes/Bispecific-Antibodies-in-Myeloma-The-Who--What--When--and-Where-e22k717

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →creators.spotify.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Albany Medical College (1990), accelerated BS-MD program

    1990
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
  • Internal Medicine residency

    Strong Memorial Hospital, University of Rochester

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
  • Hematology/Oncology fellowship

    Beth Israel Deaconess Medical Center / Harvard Medical School (also City of Hope, Dana-Farber Cancer Institute per secondary source)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
  • Board Certified

    American Board of Internal Medicine, Hematology (ABMS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
  • B.S.

    Union College, Schenectady, NY (Cum Laude, Phi Beta Kappa)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗

Editorial & leadership roles

journal and society appointments
  • Chair

    SWOG Barlogie-Salmon Myeloma Committee

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swog.org ↗
  • Chair

    SWOG S1803 DRAMMATIC study (Phase 3, post-transplant maintenance in myeloma)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swog.org ↗
  • Director

    City of Hope Judy and Bernard Briskin Center for Multiple Myeloma Research (past decade per SWOG bio)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →swog.org ↗
  • Former Chair

    ASCO Plasma Cell Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗
  • Former Co-Chair

    CIBMTR (Center for International Blood and Marrow Transplant Research) Plasma Cell Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗
  • Former Chair

    Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cancercenter.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Clinical Advisor

    Sutro Biopharma

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
  • Faculty

    City of Hope Comprehensive Cancer Center Hematologic Malignancies Program

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cityofhope.org ↗

Media & interviews

press, podcasts and appearances
  • VJHemOnc

    multiple video interviews on myeloma treatment (e.g., 'Sequencing of BCMA-directed therapies for multiple myeloma')

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vjhemonc.com ↗
  • OncLive

    recurring contributing author/interviewee on multiple myeloma coverage

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • TargetedOnc

    video interview 'Key Innovations and Ongoing Challenges in Multiple Myeloma Treatment'

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →targetedonc.com ↗
  • City of Hope 'Hope Talks'

    video with patient Todd Kennedy on multiple myeloma standard of care

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • Blood Cancers Today

    contributing author, MD, FACP byline

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerstoday.com ↗
  • CancerNetwork

    contributing author on myeloma topics

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
  • HealthTree for Multiple Myeloma

    patient-facing community conversation event (SoCal Myeloma Community)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthtree.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.